$65,469,511
ABBOTT: TO CONDUCT CLINICAL TRAINING AND VALIDATION STUDIES TO SUPPORT A FUTURE FDA MARKETING APPLICATION WITH AN EXPANDED INDICATION FOR USE OF THE ABBOTT TBI TEST ? TO AID IN THE DIAGNOSIS OF TRAUMATIC BRAIN INJURY IN ADULTS AND PEDIATRIC PATIENTS.
Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.
What the model surfaced from this award
Abbott conducts clinical training and validation studies for an expanded FDA marketing application of a traumatic brain injury diagnostic test.
Advancing TBI diagnostics improves clinical outcomes for military personnel, athletes, and trauma patients while supporting Abbott's regulatory pathway for expanded pediatric use.
Success signals demand for Abbott's diagnostic platforms and supporting laboratory infrastructure, benefiting clinical lab suppliers and reagent manufacturers.
Diagnostic innovation in TBI detection strengthens U.S. medical device leadership against international competitors in point-of-care testing markets.
Generated by award_classification v2.0.0 via claude-haiku-4-5-20251001 on 2026-05-15. Cost: $0.002258.
- USAspending.gov — all awards for this UEI →
- SAM.gov entity registration →
- Award record ingested from usaspending. Source identifier CONT_AWD_75A50122C00046_7505_-NONE-_-NONE-.
The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.